Study Suggests GLP-1 Drugs May Not Significantly Reduce Muscle Mass, Emphasizes Exercise
A new study published in Cell Reports Medicine suggests that GLP-1 drugs, such as Ozempic and Wegovy, may not significantly reduce muscle mass as previously thought. The research, which involved both mice and human participants, found that while some muscle loss occurs, it is less than previously reported and is outweighed by fat loss. The study highlights the importance of exercise when taking these medications, as it can enhance the health benefits of the drugs. The findings are significant given the growing use of GLP-1 drugs for weight loss and diabetes management. 
